Page last updated: 2024-08-24

4-aminoquinoline and Neoplasms

4-aminoquinoline has been researched along with Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chauhan, B; Khede, MK; Nandi, S; Tarannum, H1
Lee, H; Pundir, S; Solomon, VR1
Al-Said, MS; Arafa, RK; Ghorab, MM1
Arimondo, PB; Ausseil, F; Bouhlel, MA; Cantagrel, F; David-Cordonnier, MH; Dufau, I; Faux, C; Fleury, L; Gros, C; Labella, D; Lacroix, L; Mai, A; Mourey, L; Nahoum, V; Rilova, E; Valente, S1

Other Studies

4 other study(ies) available for 4-aminoquinoline and Neoplasms

ArticleYear
Multi-target Polypharmacology of 4-aminoquinoline Compounds against Malaria, Tuberculosis and Cancer.
    Current topics in medicinal chemistry, 2023, Volume: 23, Issue:5

    Topics: Aminoquinolines; Humans; Malaria; Neoplasms; Polypharmacology; Tuberculosis

2023
Examination of novel 4-aminoquinoline derivatives designed and synthesized by a hybrid pharmacophore approach to enhance their anticancer activities.
    Scientific reports, 2019, 04-19, Volume: 9, Issue:1

    Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Drug Screening Assays, Antitumor; HeLa Cells; Humans; MCF-7 Cells; Neoplasms

2019
Design, synthesis and potential anti-proliferative activity of some novel 4-aminoquinoline derivatives.
    Acta pharmaceutica (Zagreb, Croatia), 2014, Volume: 64, Issue:3

    Topics: Aminoquinolines; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Design; Female; Humans; Inhibitory Concentration 50; MCF-7 Cells; Molecular Structure; Neoplasms; Structure-Activity Relationship

2014
New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors.
    The Journal of biological chemistry, 2015, Mar-06, Volume: 290, Issue:10

    Topics: Aminoquinolines; DNA; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Epigenomics; Humans; Neoplasms; Pyrimidines

2015